Control strategies for synthetic therapeutic peptide APIs: Part II: raw material considerations: USP evaluates raw materials used in the chemical synthesis of peptides

Saved in:
Bibliographic Details
Published in:Pharmaceutical technology Europe 2014-04, Vol.26 (4), p.38
Main Authors: Eggen, Ivo, Gregg, Brian, Rode, Harold, Swietlow, Aleksander, Verlander, Michael, Szajek, Anita
Format: Article
Language:English
Subjects:
Drug discovery
Laws, regulations and rules
Pharmaceutical industry
Pharmaceutical research
Production processes
Raw materials
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by
cites
container_end_page
container_issue 4
container_start_page 38
container_title Pharmaceutical technology Europe
container_volume 26
creator Eggen, Ivo
Gregg, Brian
Rode, Harold
Swietlow, Aleksander
Verlander, Michael
Szajek, Anita
description
format article
fullrecord <record><control><sourceid>gale</sourceid><recordid>TN_cdi_gale_infotracmisc_A371470674</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A371470674</galeid><sourcerecordid>A371470674</sourcerecordid><originalsourceid>FETCH-LOGICAL-g1424-a770511f1fe863ed3ddc296aecae260457c8bac8a34e63c1c0304fb60517c80d3</originalsourceid><addsrcrecordid>eNptkG9LwzAQxvtCwTn9Dge-tZIubbPt3Rj-KQwc6F6PLL10kS4dvVTxE_k1vTKFDUYgd1x-z_NwuYgGicpkrCa5uoquiT6E4EEmB9HPvPGhbWqg0OqAlUMC27RA3z5sMTgDXFq9x67v97gPrkSYLQuawlK3AYpiCq3-gh2rW6drMI0nZtjNcTeF1dsS8FPXHQN0ghJ0hCU432eA2eLOGTY4RJMjaOx_It1El5YVePtXh9Hq6fF9_hIvXp-L-WwRV0k6SmOtlMiSxCYWx7nEUpalGU1yjUbjKBdppsx4o81YyxRzaRIjpEjtJmcRv4hSDqO7g2-la1w7bxv-F7NzZNYzqZJUiVylTMVnqAo9r103Hq3j8Qn_cIbnU_Y7nxXcHwk2HTmPxBe5ahuo0h3RMf4LWVGZVA</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Control strategies for synthetic therapeutic peptide APIs: Part II: raw material considerations: USP evaluates raw materials used in the chemical synthesis of peptides</title><source>Business Source Ultimate</source><source>EZB Electronic Journals Library</source><creator>Eggen, Ivo ; Gregg, Brian ; Rode, Harold ; Swietlow, Aleksander ; Verlander, Michael ; Szajek, Anita</creator><creatorcontrib>Eggen, Ivo ; Gregg, Brian ; Rode, Harold ; Swietlow, Aleksander ; Verlander, Michael ; Szajek, Anita</creatorcontrib><identifier>ISSN: 1753-7967</identifier><language>eng</language><publisher>MJH Life Sciences Media</publisher><subject>Drug discovery ; Laws, regulations and rules ; Pharmaceutical industry ; Pharmaceutical research ; Production processes ; Raw materials</subject><ispartof>Pharmaceutical technology Europe, 2014-04, Vol.26 (4), p.38</ispartof><rights>COPYRIGHT 2014 MJH Life Sciences Media</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780</link.rule.ids></links><search><creatorcontrib>Eggen, Ivo</creatorcontrib><creatorcontrib>Gregg, Brian</creatorcontrib><creatorcontrib>Rode, Harold</creatorcontrib><creatorcontrib>Swietlow, Aleksander</creatorcontrib><creatorcontrib>Verlander, Michael</creatorcontrib><creatorcontrib>Szajek, Anita</creatorcontrib><title>Control strategies for synthetic therapeutic peptide APIs: Part II: raw material considerations: USP evaluates raw materials used in the chemical synthesis of peptides</title><title>Pharmaceutical technology Europe</title><subject>Drug discovery</subject><subject>Laws, regulations and rules</subject><subject>Pharmaceutical industry</subject><subject>Pharmaceutical research</subject><subject>Production processes</subject><subject>Raw materials</subject><issn>1753-7967</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2014</creationdate><recordtype>article</recordtype><recordid>eNptkG9LwzAQxvtCwTn9Dge-tZIubbPt3Rj-KQwc6F6PLL10kS4dvVTxE_k1vTKFDUYgd1x-z_NwuYgGicpkrCa5uoquiT6E4EEmB9HPvPGhbWqg0OqAlUMC27RA3z5sMTgDXFq9x67v97gPrkSYLQuawlK3AYpiCq3-gh2rW6drMI0nZtjNcTeF1dsS8FPXHQN0ghJ0hCU432eA2eLOGTY4RJMjaOx_It1El5YVePtXh9Hq6fF9_hIvXp-L-WwRV0k6SmOtlMiSxCYWx7nEUpalGU1yjUbjKBdppsx4o81YyxRzaRIjpEjtJmcRv4hSDqO7g2-la1w7bxv-F7NzZNYzqZJUiVylTMVnqAo9r103Hq3j8Qn_cIbnU_Y7nxXcHwk2HTmPxBe5ahuo0h3RMf4LWVGZVA</recordid><startdate>20140401</startdate><enddate>20140401</enddate><creator>Eggen, Ivo</creator><creator>Gregg, Brian</creator><creator>Rode, Harold</creator><creator>Swietlow, Aleksander</creator><creator>Verlander, Michael</creator><creator>Szajek, Anita</creator><general>MJH Life Sciences Media</general><scope>N95</scope><scope>XI7</scope></search><sort><creationdate>20140401</creationdate><title>Control strategies for synthetic therapeutic peptide APIs: Part II: raw material considerations: USP evaluates raw materials used in the chemical synthesis of peptides</title><author>Eggen, Ivo ; Gregg, Brian ; Rode, Harold ; Swietlow, Aleksander ; Verlander, Michael ; Szajek, Anita</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-g1424-a770511f1fe863ed3ddc296aecae260457c8bac8a34e63c1c0304fb60517c80d3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2014</creationdate><topic>Drug discovery</topic><topic>Laws, regulations and rules</topic><topic>Pharmaceutical industry</topic><topic>Pharmaceutical research</topic><topic>Production processes</topic><topic>Raw materials</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Eggen, Ivo</creatorcontrib><creatorcontrib>Gregg, Brian</creatorcontrib><creatorcontrib>Rode, Harold</creatorcontrib><creatorcontrib>Swietlow, Aleksander</creatorcontrib><creatorcontrib>Verlander, Michael</creatorcontrib><creatorcontrib>Szajek, Anita</creatorcontrib><collection>Gale Business Insights</collection><collection>Business Insights: Essentials</collection><jtitle>Pharmaceutical technology Europe</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Eggen, Ivo</au><au>Gregg, Brian</au><au>Rode, Harold</au><au>Swietlow, Aleksander</au><au>Verlander, Michael</au><au>Szajek, Anita</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Control strategies for synthetic therapeutic peptide APIs: Part II: raw material considerations: USP evaluates raw materials used in the chemical synthesis of peptides</atitle><jtitle>Pharmaceutical technology Europe</jtitle><date>2014-04-01</date><risdate>2014</risdate><volume>26</volume><issue>4</issue><spage>38</spage><pages>38-</pages><issn>1753-7967</issn><pub>MJH Life Sciences Media</pub></addata></record>
fulltext fulltext
identifier ISSN: 1753-7967
ispartof Pharmaceutical technology Europe, 2014-04, Vol.26 (4), p.38
issn 1753-7967
language eng
recordid cdi_gale_infotracmisc_A371470674
source Business Source Ultimate; EZB Electronic Journals Library
subjects Drug discovery
Laws, regulations and rules
Pharmaceutical industry
Pharmaceutical research
Production processes
Raw materials
title Control strategies for synthetic therapeutic peptide APIs: Part II: raw material considerations: USP evaluates raw materials used in the chemical synthesis of peptides
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-25T12%3A34%3A46IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Control%20strategies%20for%20synthetic%20therapeutic%20peptide%20APIs:%20Part%20II:%20raw%20material%20considerations:%20USP%20evaluates%20raw%20materials%20used%20in%20the%20chemical%20synthesis%20of%20peptides&rft.jtitle=Pharmaceutical%20technology%20Europe&rft.au=Eggen,%20Ivo&rft.date=2014-04-01&rft.volume=26&rft.issue=4&rft.spage=38&rft.pages=38-&rft.issn=1753-7967&rft_id=info:doi/&rft_dat=%3Cgale%3EA371470674%3C/gale%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-g1424-a770511f1fe863ed3ddc296aecae260457c8bac8a34e63c1c0304fb60517c80d3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_id=info:pmid/&rft_galeid=A371470674&rfr_iscdi=true